← All trials
NCT05307874
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 19, 2022
- Primary completion
- Dec 31, 2023
- Completion date
- Dec 31, 2023
- First posted
- Apr 1, 2022
- Last posted
- Oct 7, 2022
- Enrollment
- 75
- Arms / groups
- 8 / —
- Source
- AACT · ctgov ingestion
Sponsors
- ImCheck TherapeuticsLead sponsor
- ExystatCollaborator
- ImCheck TherapeuticsStudy director
- ImCheck TherapeuticsOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.